Astrazeneca plc (AZN)
Income statement / TTM
Jun'18Jun'17
Product Sales

0

0

Externalisation Revenue

0

0

Total Revenue

0

0

Cost of sales

0

0

Gross profit

0

0

Distribution costs

0

0

Research and development expense

0

0

Selling, general and administrative costs

0

0

Other operating income & expense

0

0

Operating profit

0

0

Finance income

0

0

Finance expense

0

0

Share of after tax losses in associates and joint ventures

0

0

Profit before tax

0

0

Taxation

0

0

Profit for the period

0

0

Other comprehensive income:
Remeasurement of the defined benefit pension liability

0

0

Fair value movements on equity investments

0

-

Fair value movements related to own credit risk on bonds designated as fair value through profit or loss

0

-

Tax on items that will not be reclassified to profit or loss

0

0

Total other comprehensive income that will not be reclassified to profit or loss, net of tax

0

0

Foreign exchange arising on consolidation

0

0

Foreign exchange arising on designating borrowings in net investment hedges

0

0

Fair value movements on cash flow hedges

0

0

Fair value movements on cash flow hedges transferred to profit or loss

0

0

Fair value movements on derivatives designated in net investment hedges

0

0

Amortisation of loss on cash flow hedge

0

0

Fair value movements on equity investments

0

0

Tax on items that may be reclassified subsequently to profit or loss

0

0

Total other comprehensive income that will be reclassified to profit or loss, net of tax

0

0

Other comprehensive (loss) / income for the period, net of tax

0

0

Total comprehensive income for the period

0

0

Owners of the Parent

0

0

Non-controlling interests

0

0

Total comprehensive income attributable to:
Owners of the Parent

0

0

Non-controlling interests

0

0

Total comprehensive income for the period

0

0

Basic earnings loss per (in dollars per share)

0.27

0.38

Diluted earnings loss per Share (in dollars per share)

0.27

0.38

Weighted average number of Ordinary Shares in issue for basic earnings

1,267,000,000

1,266,000,000

Diluted weighted average number of Ordinary Shares in issue (millions)

1,267,000,000

1,267,000,000